Keep pulling the thread on Ben Lamm.
Colossal has achieved the ability to make over 50 simultaneous genetic edits in a single cell line.
Peer-reviewed papers estimate that the protection of forest elephants adds over $500 billion in value to the African economy through factors like ecotourism.
Colossal has raised $435 million for the company and an additional $50 million for its associated foundation.
Colossal is the first organization to successfully insert ancient DNA into a living species using multiplex editing with 100% efficiency.
Colossal has spun out three companies: a computational biology platform for human healthcare, a plastic degradation company named Breaking, and an unannounced company valued at over $100 million.
Colossal's long-term business model is based on ecosystem restoration projects funded by certified nature credits and ecotourism, which the company projects could generate billions of dollars in annual recurring revenue.
Using the same technology developed for the dire wolf, Colossal has successfully cloned four red wolves, a species with only 15 individuals remaining in the wild.
It is forecasted that approximately 50% of all biodiversity will be lost by the year 2050.
Colossal is now capable of making over 50 genetic edits simultaneously in a single process.
Colossal is actively researching a "universal egg" concept to create an egg cell that can accept any nucleus with a low probability of mitochondrial rejection, which would be a breakthrough for interspecies surrogacy.
Woolly mammoths are more closely related to Asian elephants than Asian elephants are to African elephants.
Colossal's six-month-old dire wolf proxies currently weigh 85 pounds and are on a growth trajectory to reach a final weight of 140-150 pounds.